Advertisement
BrainsWay Ltd.

BrainsWay Ltd. (BWAY) Stock Overview

Explore BrainsWay Ltd.’s financial performance, market position, analyst ratings, and future outlook.

BWAYNASDAQ
HealthcareMedical - Devices
$14.48
$0.06(0.41%)
U.S. Market opens in 54h 49m
Advertisement

BrainsWay Ltd. (BWAY)

Meyka AI Score

Z

Key Financials

Market Cap567.9M
P/E Ratio39.02
EPS (TTM)$0.39
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$15.07
3 Months$21.71
1 Year Target$22.70

BWAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BrainsWay Ltd. (BWAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 48.01, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.70.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 39.02 and a market capitalization of 567.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.41%
5-Day Change
-3.40%
1-Month Change
-8.87%
3-Month Change
7.34%
6-Month Change
49.43%
Year-to-Date (YTD) Change
52.26%
1-Year Change
121.07%
3-Year Change
1159.13%
5-Year Change
186.17%
All-Time (Max) Change
160.90%

Contact Information

972 2 582 4030
Bynet Building, Jerusalem, NaN, 9777518

Company Facts

1,200 Employees
IPO DateApr 17, 2019
CountryIL
Actively Trading

Frequently Asked Questions